Prime Medicine, Inc. Employee Directory
Biotechnology ResearchMassachusetts, United States51-200 Employees
Prime Medicine is a biotechnology company based in Cambridge, Massachusetts, focused on developing therapies grounded in an advanced gene-editing approach. Its platform aims to locate the precise genomic site to edit and replace faulty DNA with a correct sequence, potentially addressing the majority of known disease-causing mutations. The company seeks to deliver one-time therapies that could provide lasting benefit for patients with genetic diseases. In the biotechnology research sector, Prime Medicine positions itself to advance a genetic therapy platform capable of addressing genetic diseases by modifying DNA. The firm is described as mid-sized and based in Cambridge, pursuing preclinical programs and scientific development. In 2026, Prime Medicine announced the appointment of Svetlana Makhni as Chief Financial Officer.